MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC
Titel:
MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC
Auteur:
Reck, Martin Nadal, Ernest Girard, Nicolas Filippi, Andrea R. Martin, Linda W. Gay, Carl M. Petersen, Cordula Gale, Davina Emeribe, Ugochinyere A. Georgoulia, Nefeli Perez, Ignacio E. Diaz Spicer, Jonathan D.